Bioethical challenges with HIV treatment as prevention

Research output: Contribution to journalArticle

Abstract

To best realize the opportunities afforded by treatment as prevention, important ethical challenges must be addressed, including those related to acceptability, safety, and effectiveness, as well as alternatives. Absent universal access to quality antiretroviral treatment, safety, fairness, and allocation must also be considered.

Original languageEnglish (US)
JournalClinical Infectious Diseases
Volume59
Issue numberSUPPL.1
DOIs
StatePublished - Jul 1 2014

Fingerprint

HIV
Safety

Keywords

  • ethics
  • HIV prevention
  • HIV treatment
  • policy

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)
  • Medicine(all)

Cite this

Bioethical challenges with HIV treatment as prevention. / Sugarman, Jeremy.

In: Clinical Infectious Diseases, Vol. 59, No. SUPPL.1, 01.07.2014.

Research output: Contribution to journalArticle

@article{92220537fd344ee9872a36797e1663a9,
title = "Bioethical challenges with HIV treatment as prevention",
abstract = "To best realize the opportunities afforded by treatment as prevention, important ethical challenges must be addressed, including those related to acceptability, safety, and effectiveness, as well as alternatives. Absent universal access to quality antiretroviral treatment, safety, fairness, and allocation must also be considered.",
keywords = "ethics, HIV prevention, HIV treatment, policy",
author = "Jeremy Sugarman",
year = "2014",
month = "7",
day = "1",
doi = "10.1093/cid/ciu246",
language = "English (US)",
volume = "59",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "SUPPL.1",

}

TY - JOUR

T1 - Bioethical challenges with HIV treatment as prevention

AU - Sugarman, Jeremy

PY - 2014/7/1

Y1 - 2014/7/1

N2 - To best realize the opportunities afforded by treatment as prevention, important ethical challenges must be addressed, including those related to acceptability, safety, and effectiveness, as well as alternatives. Absent universal access to quality antiretroviral treatment, safety, fairness, and allocation must also be considered.

AB - To best realize the opportunities afforded by treatment as prevention, important ethical challenges must be addressed, including those related to acceptability, safety, and effectiveness, as well as alternatives. Absent universal access to quality antiretroviral treatment, safety, fairness, and allocation must also be considered.

KW - ethics

KW - HIV prevention

KW - HIV treatment

KW - policy

UR - http://www.scopus.com/inward/record.url?scp=84904788682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904788682&partnerID=8YFLogxK

U2 - 10.1093/cid/ciu246

DO - 10.1093/cid/ciu246

M3 - Article

C2 - 24926031

AN - SCOPUS:84904788682

VL - 59

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - SUPPL.1

ER -